Specialized Proresolving Mediators Enhance Human B Cell Differentiation to Antibody-Secreting Cells

The resolution of inflammation is an active and dynamic process critical in maintaining homeostasis. Newly identified lipid mediators have been recognized as key players during the resolution phase. These specialized proresolving mediators (SPM) constitute separate families that include lipoxins, resolvins, protectins, and maresins, each derived from essential polyunsaturated fatty acids. New results demonstrate that SPM regulate aspects of the immune response, including reduction of neutrophil infiltration, decreased T cell cytokine production, and stimulation of macrophage phagocytic activity. The actions of SPM on B lymphocytes remain unknown. Our study shows that the novel SPM 17-hydroxydosahexaenoic acid (17-HDHA), resolvin D1, and protectin D1 are present in the spleen. Interestingly, 17-HDHA and resolvin D1, but not protectin D1, strongly increase activated human B cell IgM and IgG production. Furthermore, increased Ab production by 17-HDHA is due to augmented B cell differentiation toward a CD27+CD38+ Ab-secreting cell phenotype. The 17-HDHA did not affect proliferation and was nontoxic to cells. Increase of plasma cell differentiation and Ab production supports the involvement of SPM during the late stages of inflammation and pathogen clearance. The present study provides new evidence for SPM activity in the humoral response. These new findings highlight the potential applications of SPM as endogenous and nontoxic adjuvants, and as anti-inflammatory therapeutic molecules.

[1]  C. Serhan.  Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. , 2007, Annual review of immunology.

[2]  C. Berek,et al.  CD38 low IgG‐secreting cells are precursors of various CD38 high‐expressing plasma cell populations , 2004, Journal of leukocyte biology.

[3]  R. Phipps,et al.  CpG oligodeoxynucleotides induce cyclooxygenase-2 in human B lymphocytes: implications for adjuvant activity and antibody production. , 2007, Clinical immunology.

[4]  Neal N. Iwakoshi,et al.  Plasma cell differentiation requires the transcription factor XBP-1 , 2001, Nature.

[5]  K. Tarte,et al.  Generation of polyclonal plasmablasts from peripheral blood B cells: a normal counterpart of malignant plasmablasts. , 2002, Blood.

[6]  R. Phipps,et al.  Prostaglandins as modulators of immunity. , 2002, Trends in immunology.

[7]  C. Serhan,et al.  Chiral lipidomics of E-series resolvins: aspirin and the biosynthesis of novel mediators. , 2011, Biochimica et biophysica acta.

[8]  A. Sher,et al.  Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1 , 2005, The Journal of experimental medicine.

[9]  C. Serhan,et al.  Metabolomics‐Lipidomics of Eicosanoids and Docosanoids Generated by Phagocytes , 2011, Current protocols in immunology.

[10]  A. Simopoulos.  Omega-3 Fatty Acids in Inflammation and Autoimmune Diseases , 2002, Journal of the American College of Nutrition.

[11]  C. Serhan,et al.  Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. , 2006, The Journal of Immunology.

[12]  S. Abramson,et al.  APRIL and BAFF Promote Increased Viability of Replicating Human B2 Cells via Mechanism Involving Cyclooxygenase 21 , 2006, The Journal of Immunology.

[13]  A. Sher,et al.  Parasite-induced Lipoxin A4 Is an Endogenous Regulator of IL-12 Production and Immunopathology in Toxoplasma gondii Infection , 2002, The Journal of experimental medicine.

[14]  B. Spur,et al.  Lipoxin A4 and lipoxin B4 inhibit chemotactic responses of human neutrophils stimulated by leukotriene B4 and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. , 1989, Clinical science.

[15]  S. Tangye,et al.  Increased expression of CD27 on activated human memory B cells correlates with their commitment to the plasma cell lineage , 2005, The Journal of Immunology.

[16]  Yan Lu,et al.  Resolvin E1 Metabolome in Local Inactivation during Inflammation-Resolution1 , 2008, The Journal of Immunology.

[17]  K. Calame,et al.  Regulation of plasma-cell development , 2005, Nature Reviews Immunology.

[18]  C. Serhan,et al.  Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression , 2006, Nature Immunology.

[19]  A. Sher,et al.  Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production. , 2005, The Journal of clinical investigation.

[20]  J. Uddin,et al.  Design, synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxins. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.

[21]  C. Serhan,et al.  Lipoxin (LX)A4 and Aspirin-triggered 15-epi-LXA4 Inhibit Tumor Necrosis Factor 1α–initiated Neutrophil Responses and Trafficking: Regulators of a Cytokine–Chemokine Axis , 1999, The Journal of experimental medicine.

[22]  D. Eberhard,et al.  Pax5 Determines the Identity of B Cells from the Beginning to the End of B-lymphopoiesis , 2001, International reviews of immunology.

[23]  Makoto Arita,et al.  Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Hugh R. Brady,et al.  Cutting Edge: Lipoxins Rapidly Stimulate Nonphlogistic Phagocytosis of Apoptotic Neutrophils by Monocyte-Derived Macrophages1 , 2000, The Journal of Immunology.

[25]  R. Poulsen,et al.  Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega‐3 intake , 2008, American journal of hematology.

[26]  C. Serhan,et al.  Aspirin-Triggered Lipoxin A4 and B4 Analogs Block Extracellular Signal-Regulated Kinase-Dependent TNF-α Secretion from Human T Cells 1 , 2003, The Journal of Immunology.

[27]  Charles N. Serhan,et al.  Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators , 2008, Nature Reviews Immunology.

[28]  R. Phipps,et al.  Inhibition of cyclooxygenase‐2 impairs the expression of essential plasma cell transcription factors and human B‐lymphocyte differentiation , 2010, Immunology.

[29]  A. Brash,et al.  Detection and cellular localization of 12R-lipoxygenase in human tonsils. , 2001, Archives of biochemistry and biophysics.

[30]  T. Murant,et al.  Activated Human B Lymphocytes Express Cyclooxygenase-2 and Cyclooxygenase Inhibitors Attenuate Antibody Production1 , 2005, The Journal of Immunology.

[31]  C. Serhan,et al.  The Docosatriene Protectin D1 Is Produced by TH2 Skewing and Promotes Human T Cell Apoptosis via Lipid Raft Clustering* , 2005, Journal of Biological Chemistry.

[32]  T. Honjo,et al.  AID to overcome the limitations of genomic information , 2005, Nature Immunology.

[33]  D. Ye,et al.  BML-111, a lipoxin receptor agonist, modulates the immune response and reduces the severity of collagen-induced arthritis , 2008, Inflammation Research.

[34]  C. Serhan,et al.  Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction , 1996, The Journal of experimental medicine.

[35]  Kuo-I Lin,et al.  Blimp-1-Dependent Repression of Pax-5 Is Required for Differentiation of B Cells to Immunoglobulin M-Secreting Plasma Cells , 2002, Molecular and Cellular Biology.